Jordyn Sava News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Combining talquetamab and daratumumab could create a synergy to get more from talquetamab to attack multiple myeloma.

New orleansUnited statesBhagirathbhair dholariaJordyn savaOncology at vanderbilt university medical centerDepartment of hematologyAmerican society of clinical oncologyJanssen pharmaceuticalsAmerican society of hematologyAmerican societyClinical oncologyVanderbilt university medical centerAmerican journalManaged careBreakthrough therapy